Between 2021-2025, relatively few AHFTC fellowship programs matched most applicants. Applicants prioritize markers of hospital reputation & #Hearttx volumes over regional disease burden or geographical considerations. https://bit.ly/4nHnWXP
#HFSA2025 #JACCHF #ACCHFT @eirangorodeski.bsky.social
#HFSA2025 #JACCHF #ACCHFT @eirangorodeski.bsky.social
September 26, 2025 at 6:30 PM
Between 2021-2025, relatively few AHFTC fellowship programs matched most applicants. Applicants prioritize markers of hospital reputation & #Hearttx volumes over regional disease burden or geographical considerations. https://bit.ly/4nHnWXP
#HFSA2025 #JACCHF #ACCHFT @eirangorodeski.bsky.social
#HFSA2025 #JACCHF #ACCHFT @eirangorodeski.bsky.social
ENVAD-HF, a prospective RCT in stable HM3 #LVAD recipients, shows angiotensin–neprilysin inhibition is safe and well-tolerated, paving the way for trials of HF therapies in this population. https://bit.ly/47fJRQn
#JACCHF #ESCCongress #WCCardio #LVAD #HeartFailure #CardioSky
#JACCHF #ESCCongress #WCCardio #LVAD #HeartFailure #CardioSky
August 31, 2025 at 2:50 PM
ENVAD-HF, a prospective RCT in stable HM3 #LVAD recipients, shows angiotensin–neprilysin inhibition is safe and well-tolerated, paving the way for trials of HF therapies in this population. https://bit.ly/47fJRQn
#JACCHF #ESCCongress #WCCardio #LVAD #HeartFailure #CardioSky
#JACCHF #ESCCongress #WCCardio #LVAD #HeartFailure #CardioSky
"This bold new framework helps to identify the true cause of HFpEF in most people…& should make an enormous difference in guiding effective treatment,” says Dr. Milton Packer on his Adipokine Hypothesis published today in @JACCJournals. #ESCCongress #JACC #JACCHF https://bit.ly/4oZVcKN
August 31, 2025 at 12:57 PM
"This bold new framework helps to identify the true cause of HFpEF in most people…& should make an enormous difference in guiding effective treatment,” says Dr. Milton Packer on his Adipokine Hypothesis published today in @JACCJournals. #ESCCongress #JACC #JACCHF https://bit.ly/4oZVcKN
❤️ Heart Failure in focus at #ESCCongress. #JACCHF Editor-in-Chief Dr. Biykem Bozkurt highlights key science from Hot Line 2.
📺 Watch her Quick Takes now with #ACCAnywhere TV from ESC Congress in Madrid ⬇️
📺 Watch her Quick Takes now with #ACCAnywhere TV from ESC Congress in Madrid ⬇️
August 31, 2025 at 10:07 AM
❤️ Heart Failure in focus at #ESCCongress. #JACCHF Editor-in-Chief Dr. Biykem Bozkurt highlights key science from Hot Line 2.
📺 Watch her Quick Takes now with #ACCAnywhere TV from ESC Congress in Madrid ⬇️
📺 Watch her Quick Takes now with #ACCAnywhere TV from ESC Congress in Madrid ⬇️
🚑 #HeartFailure drives major #EMS burden but is often missed. In 25k+ statewide dyspnea cases, >50% had no prior HF Dx & just 24% were identified pre-hospital. Mortality was high. Early action matters. www.jacc.org/doi/10.1016/...
#JACCHF #CSANZ2025 #CardioSky
#JACCHF #CSANZ2025 #CardioSky
August 15, 2025 at 1:24 PM
🚑 #HeartFailure drives major #EMS burden but is often missed. In 25k+ statewide dyspnea cases, >50% had no prior HF Dx & just 24% were identified pre-hospital. Mortality was high. Early action matters. www.jacc.org/doi/10.1016/...
#JACCHF #CSANZ2025 #CardioSky
#JACCHF #CSANZ2025 #CardioSky
#NYValves2025 brings together leaders in structural heart disease: interventionalists, imagers, surgeons & HF specialists.
📚 Browse groundbreaking #JACCJournals research published to coincide with meeting presentations 👉 www.jacc.org/events/confe...
#JACC #JACCINT #JACCIMG #JACCHF #JACCCaseReports
📚 Browse groundbreaking #JACCJournals research published to coincide with meeting presentations 👉 www.jacc.org/events/confe...
#JACC #JACCINT #JACCIMG #JACCHF #JACCCaseReports
June 25, 2025 at 5:40 PM
#NYValves2025 brings together leaders in structural heart disease: interventionalists, imagers, surgeons & HF specialists.
📚 Browse groundbreaking #JACCJournals research published to coincide with meeting presentations 👉 www.jacc.org/events/confe...
#JACC #JACCINT #JACCIMG #JACCHF #JACCCaseReports
📚 Browse groundbreaking #JACCJournals research published to coincide with meeting presentations 👉 www.jacc.org/events/confe...
#JACC #JACCINT #JACCIMG #JACCHF #JACCCaseReports
Is #Aficamten Plus #Disopyramide More Effective Than Aficamten Alone in obstructive HCM?
#CardioSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @jimjanuzzi.bsky.social @robmentz.bsky.social @hvanspall.bsky.social @vietheartpa.bsky.social @load-dependent.bsky.social
#CardioSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @jimjanuzzi.bsky.social @robmentz.bsky.social @hvanspall.bsky.social @vietheartpa.bsky.social @load-dependent.bsky.social
May 9, 2025 at 3:30 AM
Is #Aficamten Plus #Disopyramide More Effective Than Aficamten Alone in obstructive HCM?
#CardioSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @jimjanuzzi.bsky.social @robmentz.bsky.social @hvanspall.bsky.social @vietheartpa.bsky.social @load-dependent.bsky.social
#CardioSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @jimjanuzzi.bsky.social @robmentz.bsky.social @hvanspall.bsky.social @vietheartpa.bsky.social @load-dependent.bsky.social
New study in #JACCHF on growth hormone (GH) replacement in patients with GH deficiency + #HFrEF
🔸 Improved exercise capacity + #QoL in GH replacement vs controls
🔸 Impetus here to screen for GH more, consider in those with residual symptoms despite #GDMT
📎: www.jacc.org/doi/10.1016/... #CardioSky
🔸 Improved exercise capacity + #QoL in GH replacement vs controls
🔸 Impetus here to screen for GH more, consider in those with residual symptoms despite #GDMT
📎: www.jacc.org/doi/10.1016/... #CardioSky
Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction: A Randomized, Double-Blind, Placebo-Controlled Trial
www.jacc.org
May 1, 2025 at 7:31 PM
New study in #JACCHF on growth hormone (GH) replacement in patients with GH deficiency + #HFrEF
🔸 Improved exercise capacity + #QoL in GH replacement vs controls
🔸 Impetus here to screen for GH more, consider in those with residual symptoms despite #GDMT
📎: www.jacc.org/doi/10.1016/... #CardioSky
🔸 Improved exercise capacity + #QoL in GH replacement vs controls
🔸 Impetus here to screen for GH more, consider in those with residual symptoms despite #GDMT
📎: www.jacc.org/doi/10.1016/... #CardioSky
📣 The 2023 @accintouch.bsky.social #AHF Staffing Survey is out!
Curious about current staffing trends in #HT #LVAD programs across the U.S.?
Check out the latest data and see how things have evolved over time.
@jaccjournals.bsky.social #JACCHF
👉 www.jacc.org/doi/10.1016/...
Curious about current staffing trends in #HT #LVAD programs across the U.S.?
Check out the latest data and see how things have evolved over time.
@jaccjournals.bsky.social #JACCHF
👉 www.jacc.org/doi/10.1016/...
The 2023 American College of Cardiology Advanced Heart Failure Staffing Survey: The Report From the ACC Council on Heart Failure and Transplantation
www.jacc.org
April 11, 2025 at 5:21 AM
📣 The 2023 @accintouch.bsky.social #AHF Staffing Survey is out!
Curious about current staffing trends in #HT #LVAD programs across the U.S.?
Check out the latest data and see how things have evolved over time.
@jaccjournals.bsky.social #JACCHF
👉 www.jacc.org/doi/10.1016/...
Curious about current staffing trends in #HT #LVAD programs across the U.S.?
Check out the latest data and see how things have evolved over time.
@jaccjournals.bsky.social #JACCHF
👉 www.jacc.org/doi/10.1016/...
Efficacy, Safety and Mechanistic Impact of a #HeartFailure Guideline-Directed Medical Therapy Clinic
#JACCHF #CardioSky #GDMT
www.jacc.org/doi/full/10....
@jimjanuzzi.bsky.social @jaccjournals.bsky.social @drmarthagulati.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social
#JACCHF #CardioSky #GDMT
www.jacc.org/doi/full/10....
@jimjanuzzi.bsky.social @jaccjournals.bsky.social @drmarthagulati.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social
April 9, 2025 at 11:50 PM
Efficacy, Safety and Mechanistic Impact of a #HeartFailure Guideline-Directed Medical Therapy Clinic
#JACCHF #CardioSky #GDMT
www.jacc.org/doi/full/10....
@jimjanuzzi.bsky.social @jaccjournals.bsky.social @drmarthagulati.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social
#JACCHF #CardioSky #GDMT
www.jacc.org/doi/full/10....
@jimjanuzzi.bsky.social @jaccjournals.bsky.social @drmarthagulati.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social
Townhall discussion offering the audience the opportunity to ask their burning questions about the practical optimization of #heartfailure management in the real world
📍s100a
#ACC25 #JACCHF
📍s100a
#ACC25 #JACCHF
March 29, 2025 at 6:45 PM
Townhall discussion offering the audience the opportunity to ask their burning questions about the practical optimization of #heartfailure management in the real world
📍s100a
#ACC25 #JACCHF
📍s100a
#ACC25 #JACCHF
📢 #JACCHF is seeking original scientific investigations, state-of-the-art reviews and brief reports for an upcoming special focus issue on the emerging area of “Screening For Heart Failure.”
Learn more and submit your science today: www.jacc.org/call-for-pap... #HeartFailure #CardioSky #MedSky
Learn more and submit your science today: www.jacc.org/call-for-pap... #HeartFailure #CardioSky #MedSky
March 21, 2025 at 3:19 PM
📢 #JACCHF is seeking original scientific investigations, state-of-the-art reviews and brief reports for an upcoming special focus issue on the emerging area of “Screening For Heart Failure.”
Learn more and submit your science today: www.jacc.org/call-for-pap... #HeartFailure #CardioSky #MedSky
Learn more and submit your science today: www.jacc.org/call-for-pap... #HeartFailure #CardioSky #MedSky
DAPA-HF and DELIVER: Treatment of severe HF across the spectrum of #LVEF with the #SGLT2 inhibitor dapagliflozin appeared to be safe and effective in reducing the risk of CV death or worsening HF.
Read more: bit.ly/41FVcVc
#heartfailure #JACCHF #CardioSky #MedSky @jaccjournals.bsky.social
Read more: bit.ly/41FVcVc
#heartfailure #JACCHF #CardioSky #MedSky @jaccjournals.bsky.social
March 10, 2025 at 5:44 PM
DAPA-HF and DELIVER: Treatment of severe HF across the spectrum of #LVEF with the #SGLT2 inhibitor dapagliflozin appeared to be safe and effective in reducing the risk of CV death or worsening HF.
Read more: bit.ly/41FVcVc
#heartfailure #JACCHF #CardioSky #MedSky @jaccjournals.bsky.social
Read more: bit.ly/41FVcVc
#heartfailure #JACCHF #CardioSky #MedSky @jaccjournals.bsky.social
Severe HF & Treatment With #Dapagliflozin Across Ejection Fraction Spectrum: DAPA-HF & DELIVER
#CardioSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @sjgreene-md.bsky.social @jimjanuzzi.bsky.social @hvanspall.bsky.social @vietheartpa.bsky.social @robmentz.bsky.social
#CardioSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @sjgreene-md.bsky.social @jimjanuzzi.bsky.social @hvanspall.bsky.social @vietheartpa.bsky.social @robmentz.bsky.social
March 9, 2025 at 1:31 PM
Severe HF & Treatment With #Dapagliflozin Across Ejection Fraction Spectrum: DAPA-HF & DELIVER
#CardioSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @sjgreene-md.bsky.social @jimjanuzzi.bsky.social @hvanspall.bsky.social @vietheartpa.bsky.social @robmentz.bsky.social
#CardioSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @sjgreene-md.bsky.social @jimjanuzzi.bsky.social @hvanspall.bsky.social @vietheartpa.bsky.social @robmentz.bsky.social
The MAPLE-HCM study evaluates #aficamten vs #metoprolol to potentially redefine first-line therapy standards in hypertrophic obstructive cardiomyopathy. Details of the study design in #JACCHF: www.jacc.org/doi/10.1016/...
#oHCM #HCMAwarenessDay
#oHCM #HCMAwarenessDay
February 26, 2025 at 8:13 PM
The MAPLE-HCM study evaluates #aficamten vs #metoprolol to potentially redefine first-line therapy standards in hypertrophic obstructive cardiomyopathy. Details of the study design in #JACCHF: www.jacc.org/doi/10.1016/...
#oHCM #HCMAwarenessDay
#oHCM #HCMAwarenessDay
Important article for patients with HF!
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social
#CardioSky #MedSky #HeartFailure #JaccHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social
#CardioSky #MedSky #HeartFailure #JaccHF
February 16, 2025 at 4:43 PM
Important article for patients with HF!
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social
#CardioSky #MedSky #HeartFailure #JaccHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social
#CardioSky #MedSky #HeartFailure #JaccHF
Beyond Guideline-Directed Medical Therapy: Nonpharmacologic Management for Patients With Heart Failure.
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social
#CardioSky #MedSky #HeartFailure #JaccHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social
#CardioSky #MedSky #HeartFailure #JaccHF
February 16, 2025 at 2:39 PM
Beyond Guideline-Directed Medical Therapy: Nonpharmacologic Management for Patients With Heart Failure.
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social
#CardioSky #MedSky #HeartFailure #JaccHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social
#CardioSky #MedSky #HeartFailure #JaccHF
#THT2025 #JACCHF LBCT: In patients with #heartfailure & #LVEF >40%, APTURE shunt confirmed acceptable safety profile with improvements in HF symptoms, #QoL, & functional capacity without negatively affecting right & left heart function after 2 years, regardless of PVD www.jacc.org/doi/10.1016/...
February 11, 2025 at 3:54 PM
#THT2025 #JACCHF LBCT: In patients with #heartfailure & #LVEF >40%, APTURE shunt confirmed acceptable safety profile with improvements in HF symptoms, #QoL, & functional capacity without negatively affecting right & left heart function after 2 years, regardless of PVD www.jacc.org/doi/10.1016/...
Original Paper:
Adverse Pregnancy Outcomes & Long-Term Risk of HF in Women: National Cohort & Co-Sibling Study
#CardioSky #CardioObstetrics #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @csilvers.bsky.social @drklindley.bsky.social @isabellemalhame.bsky.social
Adverse Pregnancy Outcomes & Long-Term Risk of HF in Women: National Cohort & Co-Sibling Study
#CardioSky #CardioObstetrics #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @csilvers.bsky.social @drklindley.bsky.social @isabellemalhame.bsky.social
January 27, 2025 at 6:46 PM
Original Paper:
Adverse Pregnancy Outcomes & Long-Term Risk of HF in Women: National Cohort & Co-Sibling Study
#CardioSky #CardioObstetrics #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @csilvers.bsky.social @drklindley.bsky.social @isabellemalhame.bsky.social
Adverse Pregnancy Outcomes & Long-Term Risk of HF in Women: National Cohort & Co-Sibling Study
#CardioSky #CardioObstetrics #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @csilvers.bsky.social @drklindley.bsky.social @isabellemalhame.bsky.social
#CardioObstetrics
Women who experienced any of five major adverse #pregnancy 🤰outcomes have increased risk of #HeartFailure up to 46 years later & need early preventive actions & long-term clinical care to reduce that risk.
bit.ly/4jniTK6 #JACCHF @jaccjournals.bsky.social
Women who experienced any of five major adverse #pregnancy 🤰outcomes have increased risk of #HeartFailure up to 46 years later & need early preventive actions & long-term clinical care to reduce that risk.
bit.ly/4jniTK6 #JACCHF @jaccjournals.bsky.social
Are Certain Adverse Pregnancy Outcomes Associated With Long-Term Increased Risk of HF? - American College of Cardiology
bit.ly
January 27, 2025 at 3:32 AM
#CardioObstetrics
Women who experienced any of five major adverse #pregnancy 🤰outcomes have increased risk of #HeartFailure up to 46 years later & need early preventive actions & long-term clinical care to reduce that risk.
bit.ly/4jniTK6 #JACCHF @jaccjournals.bsky.social
Women who experienced any of five major adverse #pregnancy 🤰outcomes have increased risk of #HeartFailure up to 46 years later & need early preventive actions & long-term clinical care to reduce that risk.
bit.ly/4jniTK6 #JACCHF @jaccjournals.bsky.social
Diuretic Potentiation Strategies in Acute Heart Failure
#CardioSky #MedSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @robmentz.bsky.social @sjgreene-md.bsky.social @vietheartpa.bsky.social @load-dependent.bsky.social @jimjanuzzi.bsky.social @dranulala.bsky.social
#CardioSky #MedSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @robmentz.bsky.social @sjgreene-md.bsky.social @vietheartpa.bsky.social @load-dependent.bsky.social @jimjanuzzi.bsky.social @dranulala.bsky.social
January 12, 2025 at 12:59 AM
Diuretic Potentiation Strategies in Acute Heart Failure
#CardioSky #MedSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @robmentz.bsky.social @sjgreene-md.bsky.social @vietheartpa.bsky.social @load-dependent.bsky.social @jimjanuzzi.bsky.social @dranulala.bsky.social
#CardioSky #MedSky #JACCHF
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @robmentz.bsky.social @sjgreene-md.bsky.social @vietheartpa.bsky.social @load-dependent.bsky.social @jimjanuzzi.bsky.social @dranulala.bsky.social
Functional Status & Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes & Outcomes
🦋 6MWD + MLWHFQ were associated with MACE independent of Mayo Stage
#CardioSky #MedSky
#JACCHF
@jaccjournals.bsky.social @anastasiasmihaili.bsky.social
www.jacc.org/doi/10.1016/...
🦋 6MWD + MLWHFQ were associated with MACE independent of Mayo Stage
#CardioSky #MedSky
#JACCHF
@jaccjournals.bsky.social @anastasiasmihaili.bsky.social
www.jacc.org/doi/10.1016/...
December 12, 2024 at 2:41 AM
Functional Status & Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes & Outcomes
🦋 6MWD + MLWHFQ were associated with MACE independent of Mayo Stage
#CardioSky #MedSky
#JACCHF
@jaccjournals.bsky.social @anastasiasmihaili.bsky.social
www.jacc.org/doi/10.1016/...
🦋 6MWD + MLWHFQ were associated with MACE independent of Mayo Stage
#CardioSky #MedSky
#JACCHF
@jaccjournals.bsky.social @anastasiasmihaili.bsky.social
www.jacc.org/doi/10.1016/...
Revisiting ICD Therapy for Primary Prevention in Patients With #HFrEF
#JACCHF #SOTA
#CardioSky #MedSky #HeartFailure
@jaccjournals.bsky.social @jimjanuzzi.bsky.social @robmentz.bsky.social @dranulala.bsky.social @hfsa.bsky.social @dreprime.bsky.social
www.jacc.org/doi/full/10....
#JACCHF #SOTA
#CardioSky #MedSky #HeartFailure
@jaccjournals.bsky.social @jimjanuzzi.bsky.social @robmentz.bsky.social @dranulala.bsky.social @hfsa.bsky.social @dreprime.bsky.social
www.jacc.org/doi/full/10....
December 11, 2024 at 10:04 PM
Revisiting ICD Therapy for Primary Prevention in Patients With #HFrEF
#JACCHF #SOTA
#CardioSky #MedSky #HeartFailure
@jaccjournals.bsky.social @jimjanuzzi.bsky.social @robmentz.bsky.social @dranulala.bsky.social @hfsa.bsky.social @dreprime.bsky.social
www.jacc.org/doi/full/10....
#JACCHF #SOTA
#CardioSky #MedSky #HeartFailure
@jaccjournals.bsky.social @jimjanuzzi.bsky.social @robmentz.bsky.social @dranulala.bsky.social @hfsa.bsky.social @dreprime.bsky.social
www.jacc.org/doi/full/10....
Management of Iron Deficiency in Heart Failure: Practical Considerations & Implementation of Evidence-Based Iron Supplementation
#CardioSky #JACCHF
@jaccjournals.bsky.social @robmentz.bsky.social @dranulala.bsky.social @hfsa.bsky.social @accintouch.bsky.social
www.jacc.org/doi/10.1016/...
#CardioSky #JACCHF
@jaccjournals.bsky.social @robmentz.bsky.social @dranulala.bsky.social @hfsa.bsky.social @accintouch.bsky.social
www.jacc.org/doi/10.1016/...
December 9, 2024 at 8:58 PM
Management of Iron Deficiency in Heart Failure: Practical Considerations & Implementation of Evidence-Based Iron Supplementation
#CardioSky #JACCHF
@jaccjournals.bsky.social @robmentz.bsky.social @dranulala.bsky.social @hfsa.bsky.social @accintouch.bsky.social
www.jacc.org/doi/10.1016/...
#CardioSky #JACCHF
@jaccjournals.bsky.social @robmentz.bsky.social @dranulala.bsky.social @hfsa.bsky.social @accintouch.bsky.social
www.jacc.org/doi/10.1016/...